S. Tarí et al. / Tetrahedron: Asymmetry 21 (2010) 2872–2878
2877
4.2.4. (R)-tert-Butyl 5-methoxy-1-oxo-2-(3-oxobutyl)-2,3-
dihydro-1H-indene-2-carboxylate 4da
CH2CH2COCH3), 1.39 (s, 9H, C(CH3)3); 13C NMR: dC = 207.4, 201.1,
169.6, 154.0, 141.7, 133.6, 128.5, 126.4, 125.6, 82.2, 60.0, 38.6,
37.4, 29.8, 28.2, 27.7; MS (EI): m/z (%) 280 (M+ÀC4H8, 28), 210
(100); HRMS (EI): m/z calcd for C14H13ClO4 (M+ÀC4H8) 280.0502,
found 280.0487; HPLC: Chiralcel AD-H, k = 210 nm, n-hexane/2-
propanol, 90:10, 1.0 mL/min, tR (minor) = 9.0 min, tR (major) =
12.2 min.
White solid; mp 93–95 °C; IR (KBr):
m 1731, 1717, 1697, 1267,
3
1155, 1107 cmÀ1
;
1H NMR: dH 7.68 (d, JH,H = 8.4 Hz, 1H, C(7)-H),
3
6.92 (d, JH,H = 8.4 Hz, 1H, C(6)-H), 6.90 (br s, 1H, C(4)-H), 3.90 (s,
2
3H, C(5)-OCH3), 3.56 (d, JH,H = 17.3 Hz, 1H, C(3)-HA), 2.94 (d,
2JH,H = 17.3 Hz, 1H, C(3)-HB), 2.69–2.43 (m, 2H, CH2CH2COCH3),
2.26–2.10 (m, 2H, CH2CH2COCH3), 2.13 (s, 3H, CH2CH2COCH3),
1.40 (s, 9H, C(CH3)3); 13C NMR: dC 207.7, 200.6, 170.3, 165.7,
155.6, 128.4, 126.2, 115.8, 109.3, 81.8, 60.1, 55.6, 38.8, 37.6, 29.8,
28.4, 27.7; MS (EI): m/z (%) 276 (M+ÀC4H8, 23), 56 (100); HRMS
4.2.9. (R)-tert-Butyl 5-bromo-1-oxo-2-(3-oxobutyl)-2,3-
dihydro-1H-indene-2-carboxylate 4ga
Greenish oil; IR (film):
m
1739, 1715, 1256, 1154 cmÀ1; 1H NMR:
3
(EI): m/z calcd for
276.0744; HPLC: Chiralcel AD-H, k = 210 nm, n-hexane/2-propanol,
80:20, 1.0 mL/min, tR (minor) = 7.9 min, tR (major) = 12.0 min.
C
15H16O5 (M+ÀC4H8) 276.0998, found
dH 7.65 (br s, 1H, C(4)-H), 7.61 (d, JH,H = 8.0 Hz, 1H, C(7)-H), 7.54
3
2
(d, JH,H = 8.0 Hz, 1H, C(6)-H), 3.59 (d, JH,H = 17.4 Hz, 1H, C(3)-HA),
2
2.99 (d, JH,H = 17.6 Hz, 1H, C(3)-HB), 2.70–2.45 (m, 2H,
CH2CH2COCH3), 2.29–2.11 (m, 2H, CH2CH2COCH3), 2.13 (s, 3H,
CH2CH2COCH3), 1.39 (s, 9H, C(CH3)3); 13C NMR: dC 207.2, 201.3,
169.5, 154.0, 134.0, 131.3, 130.5, 129.5, 125.7, 82.1, 60.0, 38.6,
37.4, 29.7, 28.1, 27.6; MS (EI): m/z (%) 324 (M+ÀC4H8, 26), 254
(100); HRMS (EI): m/z calcd for C14H13BrO4 (M+ÀC4H8) 323.9997,
found323.9978;HPLC:ChiralcelAD-H, k = 210 nm, n-hexane/2-pro-
panol, 90:10, 1.0 mL/min, tR (minor) = 9.2 min, tR (major) = 13.2 min.
4.2.5. (R)-tert-Butyl 5-methoxy-1-oxo-2-(3-oxopropyl)-2,3-
dihydro-1H-indene-2-carboxylate 4dc
Pale yellow oil; IR (film):
m
1725, 1699, 1256, 1148 cmÀ1
;
1H
3
NMR: dH 9.75 (s, 1H, CHO), 7.69 (d, JH,H = 8.4 Hz, 1H, C(7)-H),
3
6.93 (d, JH,H = 8.8 Hz, 1H, C(6)-H), 6.91 (br s, 1H, C(4)-H), 3.90 (s,
2
3H, C(5)-OCH3), 3.58 (d, JH,H = 17.4 Hz, 1H, C(3)-HA), 2.94 (d,
2JH,H = 17.2 Hz, 1H, C(3)-HB), 2.65–2.46 (m, 2H, CH2CH2CHO),
2.33–2.14 (m, 2H, CH2CH2CHO), 1.40 (s, 9H, C(CH3)3); 13C NMR:
dC 201.1, 200.4, 170.0, 165.7, 155.6, 128.2, 126.3, 115.8, 109.3,
81.9, 60.0, 55.6, 39.4, 37.4, 27.7, 26.6; MS (EI): m/z (%) 262
(M+ÀC4H8, 16), 162 (100); HRMS (EI): m/z calcd for C14H14O5
(M+ÀC4H8) 262.0841, found 262.1174; HPLC: Chiralcel AD-H,
k = 210 nm, n-hexane/2-propanol, 90:10, 1.0 mL/min, tR (minor) =
12.4 min, tR (major) = 21.9 min.
4.2.10. (R)-tert-Butyl 2,5-dioxo-3-(3-oxobutyl)-1-
phenylpyrrolidine-3-carboxylate 4ia
White solid; mp 128–129 °C; IR (KBr):
m 1735, 1714, 1389,
1372, 1197, 1151 cmÀ1 1H NMR: dH 7.51–7.47 (m, 2H, ArH),
;
7.43–7.40 (m, 1H, ArH), 7.28–7.26 (m, 2H, ArH), 3.17 (d,
2JH,H = 18.3 Hz, 1H, C(4)-HA), 2.89–2.81 (m, 1H, CH2CHAHBCOCH3),
2
2.76 (d, JH,H = 18.1 Hz, 1H, C(4)-HB), 2.62–2.54 (m, 1H, CH2CHAHB
COCH3), 2.34–2.30 (m, 2H, CH2CH2COCH3), 2.18 (s, 3H,
CH2CH2COCH3), 1.48 (s, 9H, C(CH3)3); 13C NMR: dC 207.0, 174.8,
173.8, 168.2, 131.6, 129.3, 128.9, 126.3, 83.7, 54.3, 39.5, 38.6,
30.0, 27.8, 27.4; MS (EI): m/z (%) 245 (M+ÀCO2C4H8, 7), 193
4.2.6. (R)-tert-Butyl 5-methoxy-2-(3-methoxy-3-oxopropyl)-1-
oxo-2,3-dihydro-1H-indene-2-carboxylate 4dd
Pale yellow solid; mp 97–99 °C; IR (KBr):
m
1740, 1726, 1597,
3
1268, 1152 cmÀ1
;
1H NMR: dH 7.68 (d, JH,H = 8.4 Hz, 1H, C(7)-H),
(100); HRMS (EI): m/z calcd for
C
14H15NO3 (M+ÀCO2C4H8)
6.94–6.90 (m, 2H, C(4)-H, C(6)-H), 3.89 (s, 3H, C(5)-OCH3), 3.65
245.1052, found 245.1059; HPLC: Chiralcel AS-H, k = 210 nm, n-
hexane/2-propanol, 95:5, 1.0 mL/min, tR (major) = 38.4 min, tR
(minor) = 43.5 min.
2
(s, 3H, COOCH3), 3.59 (d, JH,H = 17.3 Hz, 1H, C(3)-HA), 2.96 (d,
2JH,H = 17.3 Hz, 1H, C(3)-HB), 2.48–2.14 (m, 4H, CH2CH2COOCH3),
1.40 (s, 9H, C(CH3)3); 13C NMR: dH 200.2, 173.3, 169.9, 165.7,
155.7, 128.3, 126.3, 115.8, 109.3, 81.8, 60.4, 55.6, 51.6, 37.1, 29.6,
29.5, 27.7; MS (EI): m/z (%) 292 (M+ÀC4H8, 53), 175 (100); HRMS
(EI): m/z calcd for C15H16O6 (M+ÀC4H8) 292.0947, found
292.0945; HPLC: Chiralcel AD-H, k = 210 nm, n-hexane/2-propanol,
90:10, 1.0 mL/min, tR (minor) = 12.5 min, tR (major) = 19.7 min.
4.2.11. (R)-tert-Butyl 3-(3-methoxy-3-oxopropyl)-2,5-dioxo-1-
phenylpyrrolidine-3-carboxylate 4id
Colorless oil; IR (film):
m 1741, 1716, 1387, 1371, 1255, 1195,
1150 cmÀ1
;
1H NMR: dH 7.51–7.39 (m, 3H, ArH), 7.28–7.26 (m,
2
2H, ArH), 3.69 (s, 3H, COOCH3), 3.19 (d, JH,H = 18.2 Hz, 1H, C(4)-
2
HA), 2.79 (d, JH,H = 18.2 Hz, 1H, C(4)-HB), 2.69–2.56 (m, 1H,
4.2.7. (R)-tert-Butyl 5,6-dimethoxy-1-oxo-2-(3-oxobutyl)-2,3-
dihydro-1H-indene-2-carboxylate 4ea
CH2CHAHBCOOCH3), 2.50–2.36 (m, 3H, CH2CHAHBCOOCH3), 1.49
(s, 9H, C(CH3)3); 13C NMR: dC 174.5, 173.7, 172.7, 167.8, 131.6,
129.2, 128.8, 126.2, 83.8, 54.6, 51.9, 38.6, 29.3, 28.3, 27.7; MS
(EI): m/z (%) 261 (M+ÀCO2C4H8, 60), 188 (100); HRMS (EI): m/z
calcd for C14H15NO4 (M+ÀCO2C4H8) 261.1001, found 261.0966;
HPLC: Chiralcel AD-H, k = 210 nm, n-hexane/2-propanol, 95:5,
1.0 mL/min, tR (minor) = 22.3 min, tR (major) = 24.9 min.
Pale brown solid; mp 160–161 °C; IR (KBr):
m 1721, 1700, 1503,
1320, 1274, 1157 cmÀ1 1H NMR: dH 7.16 (s, 1H, C(7)-H), 6.89 (s,
;
1H, C(4)-H), 3.98 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 3.51 (d,
2
2JH,H = 17.0 Hz, 1H, C(3)-HA), 2.90 (d, JH,H = 17.0 Hz, 1H, C(3)-HB),
2.65–2.42 (m, 2H, CH2CH2COCH3), 2.26–2.13 (m, 2H,
CH2CH2COCH3), 2.13 (s, 3H, CH2CH2COCH3), 1.41 (s, 9H, C(CH3)3);
13C NMR: dC 207.7, 201.1, 170.3, 155.8, 149.6, 148.0, 127.8, 107.0,
104.7, 81.7, 60.1, 56.2, 55.9, 38.8, 37.4, 29.8, 28.3, 27.7; MS (EI):
m/z (%) 262 (M+ÀCO2C4H8, 45), 205 (100); HRMS (EI): m/z calcd
for C15H18O4 (M+ÀCO2C4H8) 262.1205, found 262.1202; HPLC: Chi-
ralcel AD-H, k = 210 nm, n-hexane/2-propanol, 90:10, 1.0 mL/min,
tR (minor) = 14.3 min, tR (major) = 25.6 min.
4.3. Experimental procedure for the intramolecular aldol
condensation
To a stirred solution of (R)-tert-butyl 1-oxo-2-(3-oxobutyl)-2,3-
dihydro-1H-indene-2-carboxylate (R)-4aa, (73% ee) (64 mg, 0.21
mmol) in a mixture of DMF/H2O (1:1) (1 mL) was added DL-proline
(24 mg, 0.21 mmol). The mixture was stirred vigorously at reflux
(100 °C) until the total consumption of the substrate (TLC, 4 days)
took place. The mixture was allowed to cool down at room temper-
ature and water (20 mL) was added. The mixture was extracted with
ethyl acetate (3 Â 5 mL). The combined organic layers were dried
over MgSO4, filtered, and evaporated in vacuo (15 Torr) to afford
the crude product, which was purified by crystallization from a
mixture of hexane/EtOAc.
4.2.8. (R)-tert-Butyl 5-chloro-1-oxo-2-(3-oxobutyl)-2,3-dihydro-
1H-indene-2-carboxylate 4fa
Dark green oil; IR (film): m
1735, 1708, 1599, 1253, 1150 cmÀ1; 1H
NMR: dH 7.69 (d, 3JH,H = 8.2 Hz, 1H, C(7)-H), 7.47 (br s, 1H, C(4)-H),
7.38 (d, 3JH,H = 8.5 Hz, 1H, C(6)-H), 3.59 (d, 2JH,H = 17.4 Hz, 1H, C(3)-
2
HA), 2.99 (d, JH,H = 17.5 Hz, 1H, C(3)-HB), 2.73–2.44 (m, 2H,
CH2CH2COCH3), 2.26–2.10 (m, 2H, CH2CH2COCH3), 2.14 (s, 3H,